Correlation Between U Ming and Maxigen Biotech

Can any of the company-specific risk be diversified away by investing in both U Ming and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining U Ming and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between U Ming Marine Transport and Maxigen Biotech, you can compare the effects of market volatilities on U Ming and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in U Ming with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of U Ming and Maxigen Biotech.

Diversification Opportunities for U Ming and Maxigen Biotech

0.15

Correlation Coefficient

U Ming  Maxigen Biotech

Average diversification

The 3 months correlation between 2606 and Maxigen is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding U Ming Marine Transport and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and U Ming is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on U Ming Marine Transport are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of U Ming i.e., U Ming and Maxigen Biotech go up and down completely randomly.

Pair Corralation between U Ming and Maxigen Biotech

Assuming the 90 days trading horizon U Ming Marine Transport is expected to under-perform the Maxigen Biotech. But the stock apears to be less risky and, when comparing its historical volatility, U Ming Marine Transport is 1.19 times less risky than Maxigen Biotech. The stock trades about -0.55 of its potential returns per unit of risk. The Maxigen Biotech is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  4,455  in Maxigen Biotech on September 24, 2024 and sell it today you would earn a total of  235.00  from holding Maxigen Biotech or generate 5.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

U Ming Marine Transport  vs.  Maxigen Biotech

U Ming Marine

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days U Ming Marine Transport has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, U Ming is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Maxigen Biotech

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with U Ming and Maxigen Biotech

The main advantage of trading using opposite U Ming and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if U Ming position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.

The idea behind U Ming Marine Transport and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.